Concepts of Immunity and Recent Immunization Programme against COVID-19 in India

Authors

  • Jyoti Prakash Sahoo Dept. of Agricultural Biotechnology, OUAT, Bhubaneswar, Odisha (751 003), India
  • Sudhanya Nath Dept. of Animal Nutrition, West Bengal University of Animal & Fishery Sciences, Kolkata, West Bengal (700 037), India
  • Lipi Ghosh School of Development Studies, TISS, Mumbai, Maharashtra (400 088), India
  • Kailash Chandra Samal Dept. of Agricultural Biotechnology, OUAT, Bhubaneswar, Odisha (751 003), India

Keywords:

Vaccine, COVID-19, Immune response, Co-WIN

Abstract

To safely achieve herd immunity against COVID-19, a substantial proportion of a population would need to be vaccinated, lowering the overall amount of virus able to spread in the whole population. India has leveraged its manufacturing capacity to pre-order 600 million doses of potential COVID-19 vaccine and negotiating for another billion doses, says a new global analysis of advance market commitments (AMC) for vaccine candidates against the corona virus. India is planning to start the distribution of COVID-19 vaccine first to the healthcare workers followed by other groups to be added sequentially as there are five COVID-19 vaccines under trials in India such as COVAXIN, Covishield, ZyCoV-D, Sputinik and Biological E’s novel Covid-19 vaccine. Out of these five, COVAXIN and Covishield are approved by DCGI (Drugs Controller General of India) for restricted use in emergency situation.

Downloads

Download data is not yet available.
Biotica Research Today Cover Page Vol 3 Issue 2

Downloads

Published

2021-02-06

How to Cite

[1]
Sahoo, J.P. et al. 2021. Concepts of Immunity and Recent Immunization Programme against COVID-19 in India. Biotica Research Today. 3, 2 (Feb. 2021), 103–106.

Issue

Vol. 3 No. 2 (2021): February, 2021

Section

General Article

Categories

Most read articles by the same author(s)

1 2 3 4 5 6 > >>